Frontiers Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management, BMC Bioinformatics

µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain

Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy

Cytokines Stimulate GTP Cyclohydrolase I Gene Expression in Cultured Human Umbilical Vein Endothelial Cells

Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy

µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain

Enhanced activity of human serotonin transporter variants associated with autism

A Novel Targeted Amplicon Next-Generation Sequencing Gene Panel for the Diagnosis of Common Variable Immunodeficiency Has a High Diagnostic Yield - The Journal of Molecular Diagnostics

ISPOR - Accelerating Patient Access to Next-Generation Sequencing in Oncology: A Plan of Action

PDF) Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

Frontiers Treatment of Granulomas in Patients With Ataxia Telangiectasia

Enhanced activity of human serotonin transporter variants associated with autism

A deep learning model for predicting next-generation sequencing depth from DNA sequence

Mutations detected at next generation sequencing with the Ion Ampliseq

PDF) Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq™ panel